1. <menuitem id="mw5yx"></menuitem>
      1. <tbody id="mw5yx"></tbody>

        <track id="mw5yx"></track>

              <tbody id="mw5yx"></tbody>

                INVENTING A NEW
                ROADMAP FOR BIOTECH

                Every day, we use our homegrown technologies to discover, develop, research and deliver new medicines that help people with serious diseases. Watch to see what drives us.

                Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases and rare diseases.

                Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite? technologies, such as VelocImmune? which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

                FOR 30 YEARS, OUR
                MISSION HAS BEEN TO
                USE THE POWER OF
                SCIENCE TO BRING
                NEW MEDICINES TO
                PATIENTS... OVER
                AND OVER AGAIN.

                Neil Stahl, PhD, Executive VP,
                Research and Development

                2018 annual report PDF download

                Check out our 2018 annual materials. The Responsibility Report and Annual Report are now online.

                Read our annual report
                and responsibility report

                2018 responsibility report PDF download


                • 30
                  years of scientific
                • 7,300+
                • 700+
                  employees with
                  an MD, PhD or
                  PharmD degree
                • 6TH
                  consecutive year
                  in Forbes' World's
                  Most Innovative
                • #1
                  ranking in Science
                  magazine’s global Top
                  Employer survey for six
                  of the past eight years
                • 31,000+
                  employee volunteer hours
                  for 100+ organizations
                  in 2018
                • 7
                • 94%
                  of our waste
                  diverted from
                  landfill, reaching
                  our goal
                • 100%
                  of drug candidates
                  invented and
                  developed in-house
                • 500,000+
                  exomes sequenced
                  to date
                • 100+
                  publications in 2018
                • 20
                  product candidates in
                  clinical development
                  across multiple
                  therapeutic areas
                • Shingo Institute: The Shingo Prize, 2019

                  Great Places to Work: Best Workplace in Ireland, 2019

                  Science: #1 Top Employer, 2018

                  Forbes: Top 10 Most Innovative Companies, 2018

                  Civic 50: Most Community-Minded Companies in the Nation, 2018

                  Fortune: Best Companies to Work for, 2018

                • MIT Technology Review: Top 10 Smartest Companies, 2017

                  Fortune: Future 50, 2017

                  Barron’s: World’s Best CEOs, 2016

                  Scrip Award: R&D Team of the Year, 2016

                  Crain’s New York Business: Fast 50, 2015


                We are the only biopharmaceutical company to be led by physician-scientists for more than 30 years. We consistently demonstrate our commitment to scientific excellence by counting multiple Nobel Laureates and five members of the National Academy of Sciences among our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard.

                Our leadership

                A FOCUS
                ON SCIENCE

                From our first days, science has remained our central guiding principle.

                Our journey

                怡红院在线 视频免费